A large study of Pfizer’s experimental antiviral pill, paxlovid, has found that the drug can cut hospitalisations and deaths from Covid by nearly 90%, the company has said. The US firm’s encouraging results, which are described in a press release but not yet peer-reviewed, suggest oral pills that can be taken at home are poised to take an increasing burden off hospitals that are still...
Pfizer Covid pill ‘can cut hospitalisations and deaths by nearly 90%’
P